LEXINGTON, Ky. — The Kentucky Network for Innovation and Commercialization (KYNETIC) has selected eight teams from universities across the Commonwealth for Cycle 7 project funding.
KYNETIC is a National Institutes of Health (NIH) funded Research Evaluation and Commercialization Hub (REACH) and part of the national NIH Proof-of-Concept Network.
The program offers entrepreneurial education and proof-of-concept/product development grants to accelerate the translation of academic innovations into biomedical products by investigators throughout the Commonwealth of Kentucky. The goal is to advance the most promising biomedical research innovations — including pharmaceuticals, devices and apps — from the state’s eight public universities and the 16 community and technical colleges in the Kentucky Community and Technical College System (KCTCS).
In this cycle, KYNETIC awarded grants of around $40,000 to each of the following research teams:
- Daniel Boamah, Kimberly Greene and Austin Griffiths, Western Kentucky University
- Jamie Fredericks, Eastern Kentucky University
- Mark Fritz and Guigen Zhang, University of Kentucky
- Jill Kolesar and Chris Richards, University of Kentucky
- Brittany Levy, University of Kentucky
- Christina Ralph-Nearman and Cheri Levinson, University of Louisville
- Melissa Smith and Corey Watson, University of Louisville
- Stuart Williams, Maxwell Boakye and Michael Voor, University of Louisville
The KYNETIC program is led by the University of Kentucky, the University of Louisville, the Kentucky Cabinet for Economic Development and Kentucky Commercialization Ventures, an initiative of the Kentucky Science and Technology Corporation.
The pre-application window for KYNETIC’s Cycle 8 is currently open. The deadline is July 18, 2023, at 5 p.m. EDT. Pre-applications can be submitted online here.
KYNETIC project managers are available for consultation before the submission of your pre-application and throughout the application process. You can find more information online here.
